Early stage IT and Healthcare Investing

Myogen

portfoliocompanies

company snapshot

Myogen

Myogen, a University of Colorado Medical Center-based company, developed therapeutics for the treatment of heart disease. The company's strategy was to leverage its molecular and clinical expertise in heart muscle disease to discover new therapeutic targets for drug development, and develop and add value to in-licensed products. Myogen had an initial public offering in 2003, then was acquired by Gilead Pharmaceuticals in 2006.

website
www.gilead.com
Leadership
Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share